Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in PAD

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 3, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Peripheral Arterial Disease
Interventions
BIOLOGICAL

LoFU and aADSC

Administration of low frequency ultrasound prior to administration of autologous adipose derived stem cells.

BIOLOGICAL

adipose derived stem cells

control arm will only received the adipose derived stem cells.

Trial Locations (2)

72211

Arkansas Heart Hospital, Little Rock

Arkansas Site Management Services LLC, Little Rock

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

SonaCare Medical

INDUSTRY

lead

Arkansas Heart Hospital

OTHER